PRE-CONFERENCE WORKSHOP

Sartorius Digital Solutions Forum 2025

Bioprocessing 5.0:  From Aspiration to Implementation

About the Workshop

Join us as we bring together industry innovators and leaders to showcase the latest advancements in Process Analytical Technology (PAT), Data Analytics, Process Monitoring, Control, and Process Units.

This event will feature technical talks, demonstrations, and networking opportunities, including case studies from distinguished customers and partners, providing a platform to engage with specialists, find answers to pressing questions, and connect with peers during dedicated networking sessions to explore new ways to leverage cutting-edge solutions.

The agenda will focus on pivotal themes such as digital transformation, data-driven process improvements through AI and ML, and automation and sustainability advancements powered by data. This is a unique opportunity to delve into strategies for maximizing data potential and to gain valuable insights into tools that streamline the digital journey.

Don’t miss this chance to stay ahead in the industry and enhance your knowledge and skills. We look forward to seeing you there!

Thank you.

Speakers

Steve Miller

Head of Product Management of Digital Solutions
Sartorius

Dr. Swapan K Jana

Director – R&D and Manufacturing
Serum Institute of India Pvt. Ltd

Nicholas Kee

Lead PAT Chemist
MSD Singapore

Dr. Sanjeev Gupta

Director – IPCA R&D
IPCA Mumbai India

Karthick Murugappan

Senior Scientist – PAT
MSD Singapore

Cyril Mak

Head of Process Automation Product Management
Sartorius

Tang Wenqin

Senior Research Officer I
Bioprocessing Technology Institute (BTI)

Rishubh Chadwa

Manager
Serum Institute of India Pvt. Ltd

AGENDA

AI & Automation have brought many benefits to business and society, is BioPharma Production ready and how will we keep up in our controlled and regulatory sensitive environment?   

Steve Miller- Head of Product Management of Digital Solutions, Sartorius

This presentation delves into the Serum Institute’s innovative approach to conjugate vaccine production, highlighting advanced data analytics and Quality by Design (QbD) principles. Using tools like Umetrics® Suite and BioPAT® MFCS, Serum Institute enhances yield consistency, process robustness, and scalability. Attendees will discover how real-time data and flexible QbD frameworks drive impactful advancements in vaccine manufacturing.

Dr. Swapan K Jana, Director - R&D and Manufacturing, Serum Institute of India Pvt. Ltd

This presentation describes a preliminary study on equivalency of PLS/PCA NIR models built using SIMCA® compared to current validated models developed using different software. Test models were built in SIMCA® using same calibration spectra as current models, with similar spectra pre-treatment. Equivalence was assessed by primary outputs (scores/loadings), specific model predictions and outlier diagnostics. This effort is expected to allow manufacturing sites flexibility to use different multivariate software for operability/business reasons.

Nicholas Kee - Lead PAT Chemist, MSD Singapore

Explore IPCA's transformative journey in pharmaceutical R&D and manufacturing, leveraging AI, ML, and automation to revolutionize workflows into efficient, data-driven systems. Learn how DoE, QbD, and MVDA enhance process understanding, optimization, and scalability. Discover real-world applications in scale-up, monitoring, and seamless tech transfers, showcasing how digital tools drive innovation, reduce timelines, ensure quality, and boost operational excellence.

Dr. Sanjeev Gupta - Director - IPCA R&D , IPCA Mumbai India

Traditional process monitoring relies on univariate plots, making it labour-intensive and often leading to post-process analysis. In contrast, multivariate data analysis condenses multiple plots into key visualizations, enabling Operators to quickly identify trends and anomalies. This approach serves as an early warning system, enhancing real-time monitoring, improving productivity, and reducing the risk of costly deviations.

Karthick Murugappan - Senior Scientist - PAT, MSD Singapore

Explore how Sartorius will support single-use production transition to Industry 4.0 with scalable automation solutions. Discover key directions and themes shaping the future of software and automation in the coming years

Cyril Mak - Head of Process Automation Product Management, Sartorius

Continuous cell culture offers high productivity for biologics like monoclonal antibodies but presents challenges in sustaining cell density and productivity over time. In this study, PAT tools integrated with the Ambr 250 HT system enabled automated monitoring and control of critical culture parameters. Results showed that low Biomass Specific Perfusion Rates (BSPRs) boosted cell productivity, demonstrating the power of PAT-driven, adaptive control for enhancing bioprocess outcomes.

Tang Wenqin - Senior Research Officer I, Bioprocessing Technology Institute (BTI)

At Serum Institute of India, we are advancing toward Industry 4.0 by building a digitalized biopharma production environment. Our approach integrates real-time data, process analytics, automation, and smart control systems, ensuring seamless data flow across operations. This presentation will highlight our journey to a data-driven, operator-centric infrastructure that drives product quality, efficiency, scalability, and real-time decision-making.

Rishubh Chadwa - Manager, Serum Institute of India Pvt. Ltd

Register Here:

Hosted and Sponsored By:

Cell and Gene Therapy World Summit Brochure

    Contact Form


    IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

    Download Brochure Sample

      Contact Form


      IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.